Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-06-10Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011) [Phase 3]
A Phase 3 study evaluating the efficacy and safety of different doses of losartan potassium (MK0954-011) in hypertension, with results poste…
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation [NA]
A clinical trial evaluating paricalcitol for protective effects on the inner vessel layer and anti-inflammatory activity in chronic kidney d…
-
FDA approval · 2009-05-29FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC, enabling continued access to lisinopril…
-
FDA approval · 2009-05-29FDA Approved: HYDRALAZINE HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved hydralazine hydrochloride as an original application generic drug from Glenmark Pharmaceuticals for use in treating hypertensio…
-
FDA label_change · 2009-05-20FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
The FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) from Almatica Pharma Inc., resulting in chan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-05-12Clinical Trial Update: Effect of Myoma Removal on Blood Pressure and Erythropoetin Level [NA]
This completed trial examined whether removal of uterine fibroids (myomas) affects blood pressure and erythropoietin levels in patients with…
-
FDA approval · 2009-05-11FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AZOR, a fixed-dose combination of amlodipine besilate and olmesartan medoxomil, filed by Cos…
-
CLINICAL_TRIALS research · 2009-05-08Clinical Trial Update: Impact of an IT-Based and Healthcare Professional Support Program on Patients With High Blood Pressure [NA]
This document provides an update on a clinical trial evaluating the impact of an IT-based support program for patients with hypertension.
-
CLINICAL_TRIALS research · 2009-05-07Clinical Trial Update: A Quality Improvement Plan for Hypertension Control [NA]
This clinical trial update outlines a quality improvement plan to improve hypertension control and indicates the study is completed.
-
CLINICAL_TRIALS trial_result · 2009-05-06Clinical Trial Update: Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris [NA]
A terminated clinical trial update describing the effects of intensive long-term vasodilation in hypertensive patients with microvascular an…
-
FDA approval · 2009-05-04FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide from Hikma Pharmaceuticals USA Inc., updating the labeling on an existing product.
-
FDA approval · 2009-05-04FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2009-05-04FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2009-05-04FDA Approved: AMLODIPINE BESYLATE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's original application for amlodipine besylate, a generic version, for indications including hypertens…
-
FDA approval · 2009-04-30FDA Approved: EXFORGE HCT — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved EXFORGE HCT, a fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide, through an original application for th…
-
FDA approval · 2009-04-30FDA Approved: SPIRONOLACTONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental ANDA for spironolactone, granting approval of their generic product for the …
-
FDA approval · 2009-04-29FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Triamterene and Hydrochlorothiazide submitted by BluePoint Laboratories. The product is a generi…
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy [Phase 4]
Phase 4 clinical trial (completed) evaluating whether ambulatory blood pressure monitoring improves prediction of cardiovascular events and …
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: New York City (NYC) Health eHearts Pay for Quality Pilot
The NYC Health eHearts Pay for Quality pilot trial has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-17Clinical Trial Update: Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina [Phase 4]
A Phase 4 effectiveness study evaluating ramipril and felodipine combination therapy for hypertension in Argentine patients. The trial is sp…
-
CLINICAL_TRIALS research · 2009-04-14Clinical Trial Update: National Health and Nutrition Examination Survey IV (NHANES (IV)
This entry reports the NHANES IV National Health and Nutrition Examination Survey study status as COMPLETED. The listed conditions include c…
-
CLINICAL_TRIALS trial_result · 2009-04-13Clinical Trial Update: A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin [Phase 3]
Phase 3 randomized trial evaluating the fixed combination of amlodipine and atorvastatin for hypertension and hypercholesterolemia; complete…
-
CLINICAL_TRIALS trial_result · 2009-04-10Clinical Trial Update: Strength Training in Walking Tolerance in Intermittent Claudication Patients [Phase 3]
Phase 3 trial assessing strength training to improve walking tolerance in intermittent claudication due to peripheral arterial disease compl…
-
FDA approval · 2009-04-08FDA Approved: AMLODIPINE BESYLATE — Original Application (Epic Pharma, LLC)
The FDA approved the original application for amlodipine besylate from Epic Pharma, LLC, enabling its generic version of the calcium channel…
-
FDA approval · 2009-04-06FDA Approved: PRAZOSIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for prazosin hydrochloride submitted by Prasco Laboratories.